£112.79

This is the most expensive it has ever been. Walk away.

£113 today · previous high £113 · all-time low £112

Springer Anticancer Plants: Clinical Trials and Nanotechnology: Volume 3

Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 31 days · 31 data points (no recent data)

Historical
Generating forecast…
£112.79 £111.82 £112.03 £112.24 £112.46 £112.67 £112.88 25 July 2026 01 August 2026 09 August 2026 16 August 2026 24 August 2026
View at Amazon ↗

White

Price data last checked 60 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 31 days • 2 price levels

Days at Price
Current Price
13 days 18 days · current 0 5 9 14 18 £112 £113 Days at Price

Price Analysis

Most common price: £113 (18 days, 58.1%)

Price range: £112 - £113

Price levels: 2 different prices over 31 days

Description

Cancer is one of the leading causes of death in human beings. Though several synthetic medicines are used to treat cancer, they are largely inefficient and unsafe. In contrast, plants, which have been used for medicinal purposes since time immemorial, have proved to be useful in fighting cancer, with natural compounds from plants and their derivatives offering safe and effective treatment and management for several types of cancer. Plants such as Catharanthus roseus, Podophyllum peltatum, Taxus brevifolia, Camptotheca acuminate, Andrographis paniculata, Crateva nurvala, Croton tonkinensis, Oplopanax horridus etc., are important source of chemotherapeutic compounds. These plants have proven their value in the treatment of cancer and various other infectious diseases, and several common anticancer compounds such as taxol, podophyllotoxins, camptothecin, vinblastine, vincristine, homoharringtonine etc. have been isolated and purified from these medicinal plants. Unfortunately, many of these anticancer plants have become endangered due to ruthless and irresponsible harvesting practices. Hence, there is a need to conserve these species and to propagate them on a large scale using plant tissue culture. Alternatively, plant cell tissue and organ culture biotechnology could be adopted to produce these anticancer compounds without the need for cultivation. A better grasp and continuing exploration of these isolated molecules and products could provide a powerful alternative means of reducing cancer risk. “Anticancer Plants: Volume 3, Clinical Trials and Nanotechnology” provides a timely review of concepts and experimental data on the application of anticancer plants and their compounds in clinical trials, and on the use of nanotechnology in cancer therapy.

Product Specifications

Colour
White
Format
hardcover
Domain
Amazon UK
Release Date
14 July 2018
Listed Since
28 December 2017

Barcode

No barcode data available

Similar Products You Might Like

Antitumoral Properties of Natural Products
97% match

Antitumoral Properties of Natural Products

MDPI AG

£52.06 06 Sep 2026
Anticancer Agents from Natural Products
97% match

Anticancer Agents from Natural Products

CRC Press

£45.99 26 Sep 2026
Handbook of Compounds with Cytotoxic Activity Isolated from Plants
97% match

Handbook of Compounds with Cytotoxic Activity Isolated from Plants

£99.21 11 Sep 2026
Natural Products as Anticancer Agents
97% match

Natural Products as Anticancer Agents

Elsevier

£154.99 30 Sep 2026
Antitumoral Properties of Natural Products: Volume 2
97% match

Antitumoral Properties of Natural Products: Volume 2

MDPI AG

£54.50 30 Sep 2026
Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients, and Pharmacological Outcomes
96% match

Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients, and Pharmacological Outcomes

£130.02 30 Sep 2026
Anticancer Plants: Mechanisms and Molecular Interactions Volume 4
96% match

Anticancer Plants: Mechanisms and Molecular Interactions Volume 4

Springer

£113.03 26 Aug 2026
Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)
96% match

Combination Cancer Therapy: Modulators and Potentiators (Cancer Drug Discovery and Development)

Humana

£80.67 18 Sep 2026
Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)
96% match

Anthracycline Chemistry and Biology I: Biological Occurence and Biosynthesis, Synthesis and Chemistry: 282 (Topics in Current Chemistry, 282)

Springer

£111.24 23 Aug 2026
Pharmacotherapeutic Botanicals for Cancer Chemoprevention
96% match

Pharmacotherapeutic Botanicals for Cancer Chemoprevention

Springer

£99.20 27 Sep 2026
The Chemistry of Antitumour Agents
96% match

The Chemistry of Antitumour Agents

Springer

£41.43 01 Oct 2026
Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
96% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Elsevier

£117.40 24 Sep 2026
African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and their Chemoresistance: Part 3. Potential Pharmaceuticals to Overcome ... (Advances in Botanical Research, Volume 115)
96% match

African Plant-Based Products as a Source of Potent Drugs to Overcome Cancers and their Chemoresistance: Part 3. Potential Pharmaceuticals to Overcome ... (Advances in Botanical Research, Volume 115)

Elsevier

£106.52 25 Sep 2026
Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)
96% match

Molecular and Clinical Advances in Anticancer Drug Resistance: 57 (Cancer Treatment and Research, 57)

Springer

£159.29 30 Sep 2026
Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)
96% match

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 1991: 74 (Developments in Oncology, 74)

Springer

£235.71 10 Sep 2026
Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)
96% match

Anticancer Drug Discovery and Development: Natural Products and New Molecular Models: Proceedings of the Second Drug Discovery and Development ... 27–29, 1991: 74 (Developments in Oncology)

Springer

£235.59 12 Sep 2026
Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)
96% match

Towards Dual and Targeted Cancer Therapy with Novel Phthalocyanine-based Photosensitizers (Springer Theses)

Springer

£74.81 18 Sep 2026
Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)
96% match

Cancer Chemotherapy and Selective Drug Development: Proceedings of the 10th Anniversary Meeting of the Coordinating Committee for Human Tumour ... 24–28, 1983: 23 (Developments in Oncology)

Springer

£125.34 30 Sep 2026
Cancer Biology and Therapeutics
96% match

Cancer Biology and Therapeutics

Springer

£159.08 19 Sep 2026
Cancer Chemotherapy Concepts & Clinical Developments - Volume 36
96% match

Cancer Chemotherapy Concepts & Clinical Developments - Volume 36

Springer

£113.76 21 Sep 2026
Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)
96% match

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Springer

£114.20 01 Oct 2026
Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)
96% match

Tumor Microenvironment: The Main Driver of Metabolic Adaptation: 1219 (Advances in Experimental Medicine and Biology, 1219)

Springer

£114.20 27 Sep 2026
Nutrition and Cancer Prevention: Phytochemicals Guide
96% match

Nutrition and Cancer Prevention: Phytochemicals Guide

Springer

£73.87 26 Aug 2026
Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals: 492 (Advances in Experimental Medicine and Biology)
95% match

Nutrition and Cancer Prevention: New Insights into the Role of Phytochemicals: 492 (Advances in Experimental Medicine and Biology)

Springer

£149.22 12 Sep 2026